Mold-Tek Packaging Ltd Q2 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/91vmc067fpdcsdgpvuueo73h.pdf

Key Takeaways


The Capacity Bottleneck That Ate the Year

Rao: "In the paint and FMCG, most of the products are well established, especially come to paint pails, those paint pails standards have become normal. They are like commoditized. So, there are at least 20, 30, 40 suppliers or even 50 suppliers who are able to produce paint buckets to a reasonable quality and reasonable consistency."

Pharma: The Thesis, the Traction, and the Cost

Rao: "The point what Mold-Tek is trying to drive to pharma companies is our ability to develop new products faster than anybody else. Even the leaders in pharma packaging, we are in a position to meet or exceed them in terms of new product development."

Segment-Level Performance

SegmentH1 TrendCommentary
Paint▲ RecoveringH1 volume +4.9% after a negative prior year; FY25 guided to 7–8% (down from 10%). Grasim (ABG) volumes expected stronger in H2. Realization declined on lower raw material prices and mandatory RCP usage.
Lubes▼ SoftDown ~2.5% in H1; the industry is stagnant at ±2% annually, and last year was an aberration with good growth.
Food & FMCG▬ MutedGrowth limited to ~5.2% because Mold-Tek is absent in the North. Competition in small products in the South. North facility starts contributing from January (food) and March–April (dairy, ice cream).
Pharma▬ NascentRevenue negligible in H1; 8–10 clients approved, small quantities started in October. Material contribution expected only from Q4.

Margins: Gross Up, EBITDA Stuck


Capex Cycle: Heavy Spend, Early Innings


Guidance & Commitments

CommitmentSpecificsTimeline
Printing consolidation completeRemaining 30% of machines moved once new machines arriveJanuary
Pharma capacity utilizationReach at least 25–30%From Q4 FY25
Pharma monthly run-rateCross ₹1–2 crores per monthFrom January
Two committed pharma products launchProducts cleared by clients with capacity buyback commitmentJanuary
Panipat full IML containersFull-fledged IML container production beginsJanuary
Panipat food and dairy productsIce cream and dairy packaging manufacturing beginsMarch–April
FY25 paint volume growth7–8% for full yearFY25
FY25 overall volume growthDouble-digit (down from 15% ambition)FY25
FY25 EBITDA per kgLand around ₹38/kgFY25
FY25 capex₹85–90 croresFY25
Grasim capacity expansion5,000 TPA to 7,500–8,000 TPABy March
IML printing capacity60–70% additional capacity; last machine in AprilJanuary–April
Pharma FY26 revenueMinimum ₹30–35 crores, stretch ₹50–60 croresFY26
EBITDA per kg recoveryReach ₹40/kg minimumQ1 FY26
FY26 volume growth12–15% overallFY26
FY26 capex (tentative)₹50–60 crores, subject to revisionFY26
Mahad alternative plantSet up in same or alternative locationNext 2–3 quarters
Asset turnoverCross 2.5xGoing forward (undated)

Key Metrics

MetricQ2 FY25
Revenue mix47% paint, 20% lubes, 32.4% Food & Qpack combined, 0.5% pharma
Paint revenue growth+14% YoY
Lubes revenue growth+0.9% YoY
Food & FMCG revenue growth+3.43% YoY
Qpack revenue growth+44.5% YoY
Gross margin per kg₹86, expanded
EBITDA per kg₹36.73 currently; expected to land around ₹38 for full year
IML share of total products72.57%, up from 66.7% last year
Pharma sales~₹1 crore in Q2; October alone ₹70-75 lakhs
H1 volume growth — Paint+4.9% (was negative last year)
H1 volume growth — Lubes-2.5% (was positive last year)
H1 volume growth — Food & FMCG+5.2%
H1 volume growth — Qpack+39.7%
Full-year volume growth guidanceClose to 10% (earlier 15%); FY26 expected 12% to 15%
Full-year paint segment growth guidance7% to 8% (earlier ~10%)
CAPEX committed/ spent in H1 FY25₹62 crores spent; another ₹31 crores committed; full year expected ₹85-90 crores
Pharma investment total by end FY25Close to ₹100 crores (₹34 crores this year, ₹55 crores prior two years)
Pharma revenue expectation FY25₹30 crores to ₹50 crores
Pharma revenue expectation FY26Minimum ₹30-35 crores, could reach ₹50-60 crores
Grasim/ABG H1 volumes~1,500-1,600 tons; H2 expected 2,000+ tons
Grasim capacity~5,000 tons per annum currently; expanding to 7,500-8,000 tons by March
Asset turnover ratioBelow 2 currently; historically 2-2.5
FY26 CAPEX preliminary view₹50-60 crores as of today